Becton Dickinson
This article was originally published in The Gray Sheet
Executive Summary
Files suit against Unilever, American Home Products and Carter- Wallace for infringement of patents covering the testing process used in B-D's Precise hCG home pregnancy test. B-D alleges that Unilever's Clearblue Easy pregnancy test, Clearplan Easy ovulation test and Clearview rapid tests for pregnancy, group A streptococcus and chlamydia violate the patents. American Home distributes Clearblue and Clearplan products in the U.S.; Carter- Wallace markets the Clearview line. B-D says it filed the suit after trying for more than a year to negotiate a royalty/licensing agreement with the firms. The company has successfully negotiated "several" such pacts with other firms using the testing process, according to a spokesperson.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.